在糖尿病胃肠病症中,全肠过境时间和收缩活动
Ditte S Kornum1,2,3, Christina Brock4,5,6, Tina Okdahl4,5
1Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
Journal of neurogastroenterology and motility
|April 10, 2025
概括
糖尿病性胃肠病症显著减缓了胃肠道的通行速度,并改变了肠道的运动性. 胃收缩频率增加与糖尿病患者的恶心和反流严重程度相关.
科学领域:
- 胃肠病学 胃肠病学
- 糖尿病学 糖尿病学
- 生理学 生理学 生理学
背景情况:
- 糖尿病性胃肠病症涉及全肠胃肠道动性,但机制尚未完全理解.
- 了解传输时间和收缩活动对于管理糖尿病胃肠道并发症至关重要.
研究的目的:
- 为了比较患有糖尿病胃肠病的人和没有糖尿病胃肠病的人的胃肠道过渡时间,收缩活性和pH值.
- 为了研究糖尿病胃肠道病的症状和肠道收缩活性之间的关系.
主要方法:
- 使用SmartPill技术测量了68名糖尿病胃肠病患者和37名对照患者的细分传输时间,收缩活性和pH值.
- 症状评估使用了胃衰竭枢机症状指数和胃肠症状评分表.
主要成果:
- 与对照人群相比,患有糖尿病性胃肠病症的个体表现出长时间的胃排空,两关节过渡,结肠和全肠过渡时间.
- 在糖尿病组中观察到下腹部收缩的频率和幅度,以及变化的结肠收缩性.
- 增加整体胃收缩频率与更高的恶心和反流症状得分有关.
结论:
- 糖尿病胃肠病患者和没有糖尿病胃肠病患者之间存在胃肠道过渡和运动性的显著差异.
- 胃收缩活动与糖尿病胃肠病的症状严重程度有关,特别是恶心和反流.
相关概念视频
Gastrointestinal Motility Disorders
220
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
220
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
31
This lesson explores three gastrointestinal imaging techniques: radionuclide testing, colonic transit studies, and virtual colonoscopy.
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
31
Gastric Motility
282
Gastric motility is the coordinated contraction and relaxation of stomach muscles that convert ingested food into chyme, a semi-liquid substance ready for further digestion in the intestines. The process begins with the vagus nerve inducing the relaxation of the smooth muscles in the fundus and body of the stomach, allowing these regions to expand and accommodate up to approximately 1.5 liters of food and liquid.
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
282
Factors Influencing Drug Absorption: Disease States and Pharmacology
360
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
360
Factors Influencing Drug Absorption: Anatomical Parameters
158
Drug absorption involves the movement of drugs from the point of administration into the systemic circulation. Initially, Gastrointestinal (GI) motility propels the drug through the digestive tract and into the stomach. However, the stomach's high acidity and limited surface area restrict its role in drug absorption for most drugs. The drug then moves from the stomach to the small intestine via gastric emptying, which can be slowed by various factors, including interactions with other...
158
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
190
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
190


